Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome

Recruiting N/A Interventional Study
Patients With Heart Failure Undergoing Cardiac Surgery
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
162 (estimated)
Sponsor
Medical University Innsbruck · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Patients with heart failure undergoing cardiac surgery face a significantly increased perioperative risk, yet no standardized strategy exists to mitigate this risk effectively. Current preoperative management relies on optimization of medical therapy without a structured prehabilitation approach. Given the strong association between eleveated preoperative N-terminal pro-B-type natriuretic peptide …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Indication for elective cardiac surgery in the Heart team * NTproBNP ≥ 1500 ng/L * ≥ 18 years willing to participate in trial * Written informed consent Exclusion Criteria: * Neuropsychiatric disorders / illnesses (e.g. drug addiction, alcohol abuse) that do not allow adhere…
Contacts

Can Gollmann-Tepeköylü, Prof.

+4351250480466

can.gt@i-med.ac.at

CONTACT

Leo Winter-Pölzl, MD

+4351250484591

leo.poelzl@i-med.ac.at

CONTACT